Tempus AI Scoops Up Personalis For $1.5 Billion; But Shares Dive
Tempus AI is acquiring cancer-monitoring firm Personalis for $1.5 billion, though the announcement triggered a decline in share prices for both companies.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Tempus AI has entered into a $1.5 billion stock deal to acquire Personalis, a firm specializing in cancer genomics and monitoring. The acquisition aims to integrate molecular residual disease (MRD) more tightly into the AI-enabled precision oncology platform operated by Tempus.
Coverage from Reuters, Quartz, and Fierce Biotech identifies Personalis as a cancer test maker and genomics partner. Financial reporting from Barron's and Investor's Business Daily emphasizes that shares for both companies sank following the news of the deal.
Future developments involve the integration of Personalis's capabilities into the Tempus precision oncology platform. Coverage does not specify the exact timeline for the deal's closing.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated just now.
Quick answers
What is the value of the acquisition?
The deal is valued at $1.5 billion.
How is the acquisition being funded?
According to Quartz, it is a stock deal.
How did the market react to the news?
Barron's and Investor's Business Daily report that shares for both Tempus AI and Personalis dived or sank.
Coverage (6)
- Tempus AI is acquiring cancer-monitoring firm Personalis in a $1.5 billion stock deal qz.com · 19h ago
- Tempus buys out cancer genomics partner Personalis in $1.5 billion deal Fierce Biotech · 19h ago
- Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform Business Wire · 19h ago
- Tempus AI Buys Personalis for $1.5 Billion, and Both Stocks Sink Barron's · 19h ago
- Tempus to buy cancer test maker Personalis for $1.5 billion Reuters · 19h ago
- Tempus AI Scoops Up Personalis For $1.5 Billion; But Shares Dive Investor's Business Daily · 19h ago
Topics
Related trends
Social Security checks go out July 22. Will you get paid?
Candy giant Mars Wrigley signals massive layoffs as it relocates from NJ to Chicago
Bond traders are tuning out Trump posts
The 'Surprisingly Soft' Unit That Caused Danaher To Plummet
Danaher shares are sliding despite a second-quarter earnings beat and raised guidance, driven by a "surprisingly soft" business unit.
Homeownership rate in the U.S. is lower than you think, new research finds
Nvidia details its next-generation Vera CPU for AI, setting up challenge to AMD and Intel
Nvidia is challenging Intel and AMD with the reveal of its next-generation Vera CPU designed for agentic AI server performance.